Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",erythrocyte ion transport trait,,RS:0000786,SR/Jr,male,63 days,16,,CMO:0003860,ouabain- and bumetanide-resistant red blood cell Na+ import rate,,,,3586,umol/l/h,110.0,440.0,MMO:0000772,Na+ passive permeability assay,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 35 days),111041,controlled sodium chloride content diet (0.3 %) (for 35 days) 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",erythrocyte ion transport trait,,RS:0000786,SR/Jr,male,63 days,13,,CMO:0003860,ouabain- and bumetanide-resistant red blood cell Na+ import rate,,,,3407,umol/l/h,114.0,411.0328,MMO:0000772,Na+ passive permeability assay,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 35 days),111042,controlled sodium chloride content diet (8 %) (for 35 days) 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",erythrocyte ion transport trait,,RS:0000817,SS/Jr,male,63 days,15,,CMO:0003860,ouabain- and bumetanide-resistant red blood cell Na+ import rate,,,,3803,umol/l/h,134.0,518.9798,MMO:0000772,Na+ passive permeability assay,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 35 days),111043,controlled sodium chloride content diet (0.3 %) (for 35 days) 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",erythrocyte ion transport trait,,RS:0000817,SS/Jr,male,63 days,10,,CMO:0003860,ouabain- and bumetanide-resistant red blood cell Na+ import rate,,,,5466,umol/l/h,525.0,1660.1958,MMO:0000772,Na+ passive permeability assay,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 35 days),111044,controlled sodium chloride content diet (8 %) (for 35 days)